Skip to content
lsd.com

Tennessee

Psychedelic trials in Tennessee

12 registered trials has a study site in Tennessee, and 2 are recruiting now.

12
Trials with a site here
2
Recruiting
8
Facilities

Open now

Recruiting in this state

TrialStatusPhaseSubstanceSites
PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence StudyNCT06713616 · Yale UniversityRecruitingPhase 3ketamine8
The OBSERVE ProtocolNCT06725277 · Yale UniversityRecruitingN/Aketamine8

Facilities

Where the research happens in Tennessee

FacilityCityTrials
Vanderbilt University Medical CenterNashville3
Athena CareNashville2
Clinical Neuroscience Solutions, CNS HealthcareMemphis1
Clinical Neuroscience Solutions, Inc - MemphisMemphis1
Clinical Neuroscience Solutions, Inc.Memphis1
East Tennessee State UniversityJohnson City1
Alliance for Multispecialty Research, LLC.Knoxville1
Alliance for Multispecialty Research LLCKnoxville1

Stay told

When a trial opens in Tennessee

Research alerts

Get a notification when a trial for trials in Tennessee starts recruiting

This registry is rebuilt every day. If no trial is recruiting for you today, that can change within weeks.

This form sends your email address and the topic of this page to Brevo, our email provider, which stores them on servers in the European Union. We never sell that address, never share it with anyone, and never use it for advertising. One email deletes it. What is held, and where.

All trials

Every trial with a Tennessee site

TrialStatusPhaseSubstanceSites
PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence StudyNCT06713616 · Yale UniversityRecruitingPhase 3ketamine8
The OBSERVE ProtocolNCT06725277 · Yale UniversityRecruitingN/Aketamine8
The Impact of Perioperative Ketamine Infusion on Surgical RecoveryNCT04625283 · Vanderbilt University Medical CenterCompletedPhase 4ketamine1
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"NCT06564818 · Cybin IRL LimitedActive, not recruitingPhase 3psilocybin45
A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge)NCT06941844 · Definium Therapeutics US, Inc.Active, not recruitingPhase 3lsd22
A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage)NCT06741228 · Definium Therapeutics US, Inc.Active, not recruitingPhase 3lsd34
54135419SUI3002: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for SuicideNCT03097133 · Janssen Research & Development, LLCCompletedPhase 3ketamine61
A Study to Evaluate the Safety and Efficacy of Intranasal Esketamine in Treatment-resistant DepressionNCT01998958 · Janssen Research & Development, LLCCompletedPhase 2ketamine25
Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Participants Assessed to be at Imminent Risk for SuicideNCT03185819 · Janssen Research & Development, LLCCompletedPhase 2ketamine51
MDMA in Subjects With Moderate Hepatic Impairment and Subjects With Normal Hepatic FunctionNCT03606538 · Resilient PharmaceuticalsNot yet recruitingPhase 1mdma1
Food Effects on Bioavailability of MDMA in Healthy VolunteersNCT05147402 · Resilient PharmaceuticalsCompletedPhase 1mdma1
Effect of Ketamine and Etomidate During RSI on Long Term OutcomesNCT06179485 · Vanderbilt University Medical CenterEnrolling by invitationN/Aketamine6

Site locations from ClinicalTrials.gov API v2, data build 2026-08-25.

Elsewhere

Other states